Company
Headquarters: Sydney, NSW, Australia
CEO: Dr. Michael P. Goldsworthy BSc (Hons), MSc, Ph.D., FAIP, GAICD
A$1.22 Billion
AUD as of July 1, 2024
US$810.8 Million
Silex Systems Limited engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. The company also develops cREO technology for the integration of various compound semiconductor devices with silicon wafer-based production techniques. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
Last Financial Reports Date | June 30, 2023 |
Revenue TTM | A$8.4 M |
EBITDA | A$-4,180,726 |
Gross Profit TTM | A$6.1 M |
Profit Margin | -223.00% |
Operating Margin | -65.79% |
Quarterly Revenue Growth | -24.20% |
Silex Systems Limited has the following listings and related stock indices.
Stock: ASX: SLX wb_incandescent